Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Change in Receivables (2016 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Change in Receivables for 12 consecutive years, with -$854000.0 as the latest value for Q1 2026.

  • For Q1 2026, Change in Receivables fell 195.63% year-over-year to -$854000.0; the TTM value through Mar 2026 reached -$1.5 million, down 524.07%, while the annual FY2025 figure was $243000.0, 104.86% up from the prior year.
  • Change in Receivables hit -$854000.0 in Q1 2026 for Cartesian Therapeutics, down from $393000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $30.0 million in Q2 2024 and bottomed at -$27.2 million in Q3 2024.
  • Average Change in Receivables over 5 years is -$567823.5, with a median of -$487000.0 recorded in 2023.
  • Year-over-year, Change in Receivables surged 13591.87% in 2022 and then plummeted 5487.27% in 2024.
  • Cartesian Therapeutics' Change in Receivables stood at -$329000.0 in 2022, then skyrocketed by 395.44% to $972000.0 in 2023, then tumbled by 507.1% to -$4.0 million in 2024, then skyrocketed by 109.93% to $393000.0 in 2025, then tumbled by 317.3% to -$854000.0 in 2026.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$854000.0, $393000.0, and $368000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.